Eastman Kodak Earnings Call Highlights Operational Turnaround

Eastman Kodak Company ((KODK)) has held its Q1 earnings call. Read on for the main highlights of the call.

Eastman Kodak’s latest earnings call painted a cautiously optimistic picture, with management stressing three straight quarters of operational gains even as headline GAAP results deteriorated. Revenue, gross profit, and operational EBITDA all moved higher, supported by product launches and disciplined execution, while accounting-driven losses, higher inventory and commodity volatility weighed on reported earnings and cash.

Revenue Growth

Consolidated revenue reached $265 million, up 7% year over year, underscoring broad-based improvement across the portfolio. On a constant currency basis sales climbed 4%, with both Print and Advanced Materials & Chemicals contributing, suggesting that growth is not purely price-driven or FX-related.

Gross Profit Improvement

Gross profit rose 24% to $57 million, lifting the margin to 22% from 19% a year earlier and signaling more profitable business mix and pricing. Management highlighted that the roughly three-point margin gain reflects better execution despite persistent cost inflation and supply-chain friction.

Operational EBITDA Surge

Operational EBITDA jumped to $15 million from $2 million, a $13 million improvement that underlines the operating turnaround narrative. The company credited sharper pricing discipline and operational efficiencies, though higher manufacturing and commodity costs tempered the upside.

AM&C and Film Momentum

Advanced Materials & Chemicals posted 3% revenue growth, driven by higher demand for film and chemicals that offset softer inks and consumables. Kodak emphasized the launch of new professional still film products, including Virita 200D, and highlighted exposure on multiple high-profile productions as a branding and demand catalyst.

Commercial Print Resilience and Product Expansion

Commercial print revenue increased 9% despite heavy raw material pressure, showing resilience in a tough market. The rollout of the Sonora Ultra XR plate in Europe broadens the Sonora Ultra portfolio and underscores Kodak’s ability to keep customers supplied amid logistics and input-cost volatility.

Pharma & R&D Investments

The company’s CGMP pharmaceutical manufacturing facility is now operational, marking a strategic push into higher-value health applications. Kodak also opened an Advanced Electrophysiology Lab with SUNY Geneseo and is pursuing Class II certification, aiming to manufacture more complex, higher-margin products in the U.S.

Balance Sheet Progress and Deleveraging

Kodak reported unrestricted cash of $299 million and further strengthened its net-debt-positive position to $139 million, an $11 million improvement. A $50 million repayment on higher-rate term loans and three consecutive quarters of improving revenue, gross profit and operational EBITDA reinforce the deleveraging narrative.

Widening GAAP Net Loss

Despite operational gains, GAAP net loss widened to $16 million from $7 million a year earlier, complicating the headline story for investors. The deterioration largely reflects non-operational items rather than a step back in the core business, but it still weighs on bottom-line optics.

Derivative and Accounting Volatility

A $12 million expense from fair-value changes on an embedded derivative tied to Series B preferred stock added meaningful noise to GAAP results. Management noted that this mark-to-market adjustment, driven in part by a higher stock price, will recur quarterly and create ongoing earnings volatility.

Pension and Non-Cash Items Reducing Comparability

Pension accounting also swung against Kodak, with non-cash pension income falling to $4 million, an $18 million drop after a major plan termination. Non-cash stock-based compensation of about $5 million further pressured reported earnings, making year-over-year comparisons less straightforward for investors.

Working Capital and Cash Decline

Unrestricted cash fell by $38 million since year-end, reflecting a deliberate build in inventory ahead of a planned plant shutdown and rising commodity costs. Inventory climbed $38 million, largely within AM&C, while higher payables and lower receivables partially offset the working-capital drag.

Commodity Inflation and Supply-Chain Headwinds

Sharp moves in key commodities, including more than doubling silver prices and higher aluminum costs, drove manufacturing expense higher and pressured margins. The company also flagged ongoing logistics challenges, underscoring that supply-chain and inflation risks remain a persistent overhang on performance.

Forward-Looking Guidance and Outlook

Management aims to extend its streak of year-over-year gains in revenue, gross profit and operational EBITDA while continuing to fortify the balance sheet. They plan to keep investing in AM&C and Print, manage the impact of a planned Q2 plant shutdown through inventory build, pursue Class II pharma certification and caution that GAAP results will remain volatile due to recurring derivative remeasurements and lower pension income.

Kodak’s latest quarter shows a company steadily rebuilding its operational base even as reported GAAP earnings remain choppy. For investors, the story is one of improving core profitability, renewed product momentum and disciplined deleveraging, offset by commodity shocks, working-capital usage and accounting-driven noise that will require a longer-term lens.